Jump to ContentJump to Main Navigation
Adverse Events – Race, Inequality, and the Testing of New Pharmaceuticals - NYU Press Scholarship Online
Users without a subscription are not able to see the full content.

Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals

Jill A. Fisher


Phase I clinical trials test the safety and tolerability of new pharmaceuticals and typically pay healthy people to enroll as research participants. In addition to being exposed to the risks of taking investigational drugs, healthy volunteers are confined to residential research facilities for some portion of the clinical trial. Most healthy volunteers are African American and Hispanic men in their late twenties to early forties. Motivated by pervasive economic insecurity and racial discrimination, these individuals often enroll serially in Phase I trials to stay afloat or to get ahead. This b ... More

Keywords: clinical trials, healthy volunteers, Phase I studies, social inequalities, race, research participation, United States, pharmaceuticals, pharmaceutical industry

Bibliographic Information

Print publication date: 2020 Print ISBN-13: 9781479877997
Published to NYU Press Scholarship Online: January 2021 DOI:10.18574/nyu/9781479877997.001.0001


Affiliations are at time of print publication.

Jill A. Fisher, author
University of North Carolina at Chapel Hill